Five‐Year (2017–2022) Evolutionary Dynamics of Human Coronavirus OC43 in Southern France Based on Whole Genome Next‐Generation Sequencing

HCoV-OC43 genomes and their evolution are scarcely studied worldwide and in France, with only 361 genomes available as of October 2023. Here, an in-house PCR amplification system was implemented to obtain retrospectively by next-generation sequencing, then analyze HCoV-OC43 genomes for infections diagnosed with this virus in southern France between February 2017 and October 2022. Multiplex PCR amplification using a set of in-house primers designed with the Gemi software was carried out on residuals of HCoV-OC43 RNA-positive nasopharyngeal samples, before next-generation sequencing (NGS) using Illumina technology on a NovaSeq. 6000 instrument. HCoV-OC43 genome assembly, bioinformatic analyses, and phylogeny reconstruction were then carried out using CLC Genomics, Mafft, BioEdit, Nextstrain, Nextclade, MEGA, iTOL, RDP4, and HyPhy softwares. Spike structural predictions used AlphaFold and HyperChem. A total of 34 PCR primer pairs were designed for amplification, before NGS of amplicons generated from HCoV-OC43 genomes. A total of 185 genomes were obtained, 17, 79, and 89 belonging to Genotypes G, J, and K, respectively. These three genotypes circulated exclusively or co-circulated according to the year. A total of 303, 940, and 1300 amino acid substitutions were detected in genomes of genotypes G, J, and K, respectively, compared with reference genomes of the same genotype dating back to 2017-2018. Possible recombinations were detected for five HCoV-OC43 genomes and involved genomes classified in genotypes J or K. HCoV-OC43 genes encoding the hemagglutinin esterase, the spike, and the Nsp14 protein harbored the greatest number of sites under positive selection. Signature amino acid mutations F467V and S507G in the spike protein of genotypes J and G, respectively, were predicted to decrease the binding of 43E6 neutralizing antibody. Overall, the present study more than doubled the set of HCoV-OC43 genomes available worldwide for the 2017-2022 period and contributed to the monitoring of the HCoV-OC43 evolutionary dynamics.

Authors

Institutions

Publication Details

Journal
Journal of Medical Virology
Published
2025-12-01
DOI
https://doi.org/10.1002/jmv.70726
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Five‐Year (2017–2022) Evolutionary Dynamics of Human Coronavirus OC43 in Southern France Based on Whole Genome Next‐Generation Sequencing

Céline Boschi, Bernard La Scola, Aurélie Morand, Jean‐Christophe Lagier et al.
Journal of Medical Virology
SARS-CoV-2 and COVID-19 Research
article

Five‐Year (2017–2022) Evolutionary Dynamics of Human Coronavirus OC43 in Southern France Based on Whole Genome Next‐Generation Sequencing

Céline Boschi, Bernard La Scola, Aurélie Morand, Jean‐Christophe Lagier, Jacques Fantini, Philippe Colson, Lorlane Le Targa, M. Lefèbvre, Justine Py, Lucile Lesage, Hikmat Houmadi
article en

Abstract

HCoV-OC43 genomes and their evolution are scarcely studied worldwide and in France, with only 361 genomes available as of October 2023. Here, an in-house PCR amplification system was implemented to obtain retrospectively by next-generation sequencing, then analyze HCoV-OC43 genomes for infections diagnosed with this virus in southern France between February 2017 and October 2022. Multiplex PCR amplification using a set of in-house primers designed with the Gemi software was carried out on residuals of HCoV-OC43 RNA-positive nasopharyngeal samples, before next-generation sequencing (NGS) using Illumina technology on a NovaSeq. 6000 instrument. HCoV-OC43 genome assembly, bioinformatic analyses, and phylogeny reconstruction were then carried out using CLC Genomics, Mafft, BioEdit, Nextstrain, Nextclade, MEGA, iTOL, RDP4, and HyPhy softwares. Spike structural predictions used AlphaFold and HyperChem. A total of 34 PCR primer pairs were designed for amplification, before NGS of amplicons generated from HCoV-OC43 genomes. A total of 185 genomes were obtained, 17, 79, and 89 belonging to Genotypes G, J, and K, respectively. These three genotypes circulated exclusively or co-circulated according to the year. A total of 303, 940, and 1300 amino acid substitutions were detected in genomes of genotypes G, J, and K, respectively, compared with reference genomes of the same genotype dating back to 2017-2018. Possible recombinations were detected for five HCoV-OC43 genomes and involved genomes classified in genotypes J or K. HCoV-OC43 genes encoding the hemagglutinin esterase, the spike, and the Nsp14 protein harbored the greatest number of sites under positive selection. Signature amino acid mutations F467V and S507G in the spike protein of genotypes J and G, respectively, were predicted to decrease the binding of 43E6 neutralizing antibody. Overall, the present study more than doubled the set of HCoV-OC43 genomes available worldwide for the 2017-2022 period and contributed to the monitoring of the HCoV-OC43 evolutionary dynamics.

Journal of Medical VirologyVol. 97(12)
Inserm (FR), Aix-Marseille Université (FR), Méditerranée Infection Foundation (FR), Assistance Publique Hôpitaux de Marseille (FR), Hôpital Nord (FR), Institut de Recherche Pour le Développement (BF), Hôpital de la Timone (FR)
Openalex Percentile: Top 56%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.